Grail, Inc.

The Company believes that its existing cash , cash equivalents and short-term marketable securities will be sufficient to meet its working capital and capital expenditure needs for at least the next 12 months, as of the date these condensed consolidated financial statements are filed.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026

Upon lease commencement, the Company recognized an operating lease right-of-use asset of $ 45.1 million and a corresponding operating lease liability of $ 44.9 million, measured using an incremental borrowing rate of 6.27 %.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026

GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

The Galleri test can indicate the origin of the cancer, giving healthcare providers a roadmap of where to explore further.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include expectations and projections of our future financial performance, future tests or products, patient awareness of our products, technology, clinical studies, safety results, regulatory compliance, potential market opportunity, anticipated growth strategies, restructuring costs, sufficiency of cash on hand to finance our business, cost savings, budgets and strategies, impact of the restructuring on our operations and growth and anticipated trends in our business.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

( GRAIL or the Company ), is an innovative commercial-stage healthcare company focused on shifting the paradigm of early cancer detection.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026

The Company limits its exposure to credit losses by investing in money market funds and United States ( U.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026

We calculate Adjusted EBITDA as net income (loss) adjusted to exclude interest (income) expense, income tax expense (benefit), depreciation, impairment of goodwill and intangible assets, and amortization of intangible assets, which represent intangible assets resulting from pushdown accounting, legal and professional services fees related to Illumina s acquisition of the Company in August 2021 ( the Acquisition ) and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and our divestment from Illumina, restructuring charges, and stock-based compensation.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include expectations and projections of our future financial performance, future tests or products, patient awareness of our products, technology, clinical studies, safety results, regulatory compliance, potential market opportunity, anticipated growth strategies, restructuring costs, sufficiency of cash on hand to finance our business, cost savings, budgets and strategies, impact of the restructuring on our operations and growth and anticipated trends in our business.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

Forward-looking statements relate to the future and, accordingly, are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

(3) Represents legal and professional services costs associated with the Acquisition and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and legal and professional services costs associated with the divestiture.

SEC original ↗Grail, Inc. — Earnings release (8-K exhibit)EX-99Aug 12, 2025

Legal Proceedings 42 Item 1A.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026

LEGAL PROCEEDINGS, COMMITMENTS, AND CONTINGENCIES The Company is subject to various claims, complaints, regulatory proceedings, and legal actions that arise from time to time in the ordinary course of business.

SEC original ↗Grail, Inc. — 10-Q Quarterly report10-QAug 6, 2026